A cost-utility analysis of neonatal circumcision

被引:38
|
作者
Van Howe, RS [1 ]
机构
[1] Michigan State Univ, Coll Human Med, Dept Pediat, Marquette, MI USA
关键词
circumcision; phimosis; cost-utility analysis; circumcision complications; penile cancer;
D O I
10.1177/0272989X04271039
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A cost-utility analysis, based on published data from multiple observational studies, comparing boys circumcised at birth and those not circumcised was undertaken using the Quality of Well-being Scale, a Markov analysis, the standard reference case, and a societal perspective. Neonatal circumcision increased incremental costs by $828.42 per patient and resulted in an incremental 15.30 well-years lost per 1000 males. If neonatal circumcision was cost-free, pain-free, and had no immediate complications, it was still more costly than not circumcising. Using sensitivity analysis, it was impossible to arrange a scenario that made neonatal circumcision cost-effective. Neonatal circumcision is not good health policy, and support for it as a medical procedure cannot be justified financially or medically.
引用
收藏
页码:584 / 601
页数:18
相关论文
共 50 条
  • [21] Cost-Utility Analysis in Probabilistic Models
    Baier, Christel
    2016 10TH INTERNATIONAL SYMPOSIUM ON THEORETICAL ASPECTS OF SOFTWARE ENGINEERING (TASE), 2016, : 1 - 1
  • [22] Cost-utility analysis of taxane therapy
    Yee, GC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 : S11 - S15
  • [23] Standardizing cost-utility analysis in neurosurgery
    Ament, Jared D.
    Kim, Kee D.
    NEUROSURGICAL FOCUS, 2012, 33 (01)
  • [24] COST-UTILITY ANALYSIS OF THROMBOLYTIC THERAPY
    SIMOONS, ML
    VOS, J
    MARTENS, LL
    EUROPEAN HEART JOURNAL, 1991, 12 (06) : 694 - 699
  • [25] Condom distribution: a cost-utility analysis
    Bedimo, AL
    Pinkerton, SD
    Cohen, DA
    Gray, B
    Farley, TA
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (06) : 384 - 392
  • [26] Patient preferences and cost-utility analysis
    Elnitsky, CA
    Stone, P
    APPLIED NURSING RESEARCH, 2005, 18 (02) : 74 - 76
  • [27] USE OF THE EUROQOL IN COST-UTILITY ANALYSIS
    DECHARRO, F
    VANBUSSCHBACH, J
    QUALITY OF LIFE RESEARCH, 1994, 3 (01) : 51 - 51
  • [28] Cost-utility analysis of rimonabant in the treatment of obesity
    Hampp, C
    Hartzema, AG
    VALUE IN HEALTH, 2006, 9 (03) : A90 - A90
  • [29] Cost-utility analysis of the cochlear implant in children
    Cheng, AK
    Rubin, HR
    Powe, NR
    Mellon, NK
    Francis, HW
    Niparko, JK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07): : 850 - 856
  • [30] COST-UTILITY ANALYSIS OF LORCASERIN IN THE TREATMENT OF OBESITY
    Sharif, Z.
    Peikanpour, M.
    Rangchian, M.
    Moghadam, Foroughi M. J.
    VALUE IN HEALTH, 2016, 19 (07) : A590 - A591